Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
49.25
+1.49 (3.12%)
Mar 23, 2026, 4:00 PM EDT - Market closed
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of $2.83 billion as of March 23, 2026. Its market cap has increased by 59.33% in one year.
Market Cap
2.83B
Enterprise Value
2.56B
1-Year Change
59.33%
Ranking
Category
Stock Price
$49.25
Market Cap Chart
Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from $133.80M to $2.83B, an increase of 2,014.93%. That is a compound annual growth rate of 24.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 2.75B | -3.50% |
| Dec 31, 2025 | 2.85B | 42.73% |
| Dec 31, 2024 | 2.00B | 26.29% |
| Dec 29, 2023 | 1.58B | -18.01% |
| Dec 30, 2022 | 1.93B | 24.34% |
| Dec 31, 2021 | 1.55B | 16.99% |
| Dec 31, 2020 | 1.33B | 6.53% |
| Dec 31, 2019 | 1.24B | -28.32% |
| Dec 31, 2018 | 1.74B | -15.02% |
| Dec 29, 2017 | 2.04B | 63.41% |
| Dec 30, 2016 | 1.25B | 90.13% |
| Dec 31, 2015 | 657.50M | 84.54% |
| Dec 31, 2014 | 356.30M | 39.62% |
| Dec 31, 2013 | 255.20M | 45.08% |
| Dec 31, 2012 | 175.90M | 31.46% |
| May 1, 2012 | 133.80M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkermes | 4.69B |
| Amneal Pharmaceuticals | 3.72B |
| Kiniksa Pharmaceuticals International, | 3.53B |
| Liquidia | 3.21B |
| Prestige Consumer Healthcare | 2.89B |
| BioCryst Pharmaceuticals | 2.43B |
| HUTCHMED (China) | 2.40B |
| Phibro Animal Health | 2.06B |